Brok J, Buckley N, Gluud C
Centre for Clinical Intervention Research, Copenhagen University Hospital, Department 71-02, H:S Rigshospitalet, Copenhagen Ø, Denmark, DK 2100.
Cochrane Database Syst Rev. 2002(3):CD003328. doi: 10.1002/14651858.CD003328.
Self-poisoning with paracetamol (acetaminophen) is a common cause of hepatotoxicity in the Western World. Interventions for paracetamol poisoning encompass inhibition of absorption, removal from the vascular system, antidotes, and liver transplantation.
The objective was to assess the beneficial and harmful effects of interventions or combination of interventions for paracetamol overdose.
The Cochrane Hepato-Biliary Group Controlled Trials Register, The Cochrane Library, MEDLINE, EMBASE, and text searches were combined (until July 2001).
Randomised clinical trials (RCTs) and observational studies as well as human volunteer randomised trials were included. The studies could be unpublished or published as an article, an abstract, or a letter and no language limitations were applied.
All the analyses were performed according to the intention to treat. The methodological quality of the included trials was evaluated by components of methodological quality.
Nine RCTs (all small and of low methodological quality), one quasi-randomised trials, 37 observational studies, and nine randomised trials including human volunteers were identified. It was impossible to perform meta-analyses including more than two RCTs. Activated charcoal, gastric lavage, and ipecacuanha are able to reduce the absorption of paracetamol but the clinical benefit is unclear. Of these, activated charcoal seems to have the best risk-benefit ratio. N-acetylcysteine seems preferable to placebo/supportive treatment (relative risk of mortality in patients with fulminant hepatic failure = 0.65; 95% confidence interval 0.43 to 0.99), dimercaprol, and cysteamine, but N-acetylcysteine's superiority to methionine is unproven. It is not clear which N-acetylcysteine treatment protocol offers the best efficacy. No evidence supports haemoperfusion or cimetidine for paracetamol overdose. Liver transplantation has the potential to be life saving in fulminant hepatic failure, but further refinement of selection criteria for liver transplantation and evaluation of the long-term outcome are required.
REVIEWER'S CONCLUSIONS: This systematic Review has highlighted a paucity of RCTs on interventions for paracetamol overdose. Activated charcoal seems the best choice to reduce paracetamol absorption. N-acetylcysteine should be given to patients with paracetamol overdose. No N-acetylcysteine regime has been shown to be more effective than any other. It is a delicate balance when to proceed to liver transplantation, which may be life saving in patients with a poor prognosis. Interventions for paracetamol overdose need assessment in high-quality, multi-centre RCTs.
对乙酰氨基酚(扑热息痛)自我中毒是西方世界肝毒性的常见原因。对乙酰氨基酚中毒的干预措施包括抑制吸收、从血管系统清除、使用解毒剂以及肝移植。
评估对乙酰氨基酚过量干预措施或联合干预措施的有益和有害影响。
Cochrane肝胆疾病组对照试验注册库、Cochrane图书馆、医学期刊数据库(MEDLINE)、循证医学数据库(EMBASE)以及文本检索相结合(截至2001年7月)。
纳入随机临床试验(RCT)、观察性研究以及人体志愿者随机试验。这些研究可以是未发表的,或发表为文章、摘要或信函,且无语言限制。
所有分析均按照意向性分析进行。通过方法学质量的各个组成部分评估纳入试验的方法学质量。
确定了9项RCT(均规模小且方法学质量低)、1项半随机试验、37项观察性研究以及9项包含人体志愿者的随机试验。无法进行包含超过两项RCT的荟萃分析。活性炭、洗胃和吐根能减少对乙酰氨基酚的吸收,但临床益处尚不清楚。其中,活性炭似乎具有最佳的风险效益比。N - 乙酰半胱氨酸似乎优于安慰剂/支持性治疗(暴发性肝衰竭患者的死亡相对风险 = 0.65;95%置信区间0.43至0.99)、二巯丙醇和半胱胺,但N - 乙酰半胱氨酸相对于蛋氨酸的优越性尚未得到证实。不清楚哪种N - 乙酰半胱氨酸治疗方案疗效最佳。没有证据支持对乙酰氨基酚过量使用血液灌流或西咪替丁。肝移植有可能挽救暴发性肝衰竭患者的生命,但需要进一步完善肝移植的选择标准并评估长期结果。
本系统综述突出了针对对乙酰氨基酚过量干预措施的RCT数量不足。活性炭似乎是减少对乙酰氨基酚吸收的最佳选择。对乙酰氨基酚过量患者应给予N - 乙酰半胱氨酸。没有证据表明任何一种N - 乙酰半胱氨酸治疗方案比其他方案更有效。决定何时进行肝移植是一个微妙的平衡,肝移植可能挽救预后不良患者的生命。对乙酰氨基酚过量的干预措施需要在高质量、多中心的RCT中进行评估。